Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination

Lancet. 2020 Nov 21;396(10263):1614-1616. doi: 10.1016/S0140-6736(20)32318-7. Epub 2020 Nov 4.

Authors

Roy M Anderson¹, Carolin Vegvari², James Truscott², Benjamin S Collyer²

Affiliations

¹ Medical Research Council Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK. Electronic address: roy.anderson@imperial.ac.uk.
² Medical Research Council Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.

No abstract available

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Vaccines
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Humans
Immunity, Herd*
Mass Vaccination*
Pandemics / prevention & control*
Pneumonia, Viral / immunology
Pneumonia, Viral / prevention & control*
SARS-CoV-2
Viral Vaccines / immunology*

Substances

COVID-19 Vaccines
Viral Vaccines

Grants and funding